Yueh Lee, DPM
Foot & Ankle Surgery · Houston, TXNPI 1962472571
Payments from drug & device makers
What this record shows
This record is dominated by other: $87,647 of the $94,929 with a category attached, or 92.3%. Linvatec Corporation accounts for 82.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $70,012 and has fallen 99.4% since, to $398 in 2025. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $895.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$79K
- Skye Orthobiologics LLC$9K
- Treace Medical Concepts, Inc.$3K
- In2bones USA, LLC$2K
- Stryker$551
- Paratek Pharmaceuticals, Inc.$379
- plus $1K from 13 others
What the payments were for
- Consulting fees$8751%
- Travel & lodging$3,2033%
- Food & beverage$3,2043%
- Other$87,64792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 8 | $78,680 |
| Skye Orthobiologics LLC | 1 | $9,400 |
| Treace Medical Concepts, Inc. | 14 | $2,626 |
| In2bones USA, LLC | 3 | $2,138 |
| Stryker | 6 | $551 |
| Paratek Pharmaceuticals, Inc. | 21 | $379 |
| Ossio Inc | 2 | $198 |
| Merck | 24 | $196 |
| Arthrex | 2 | $155 |
| Amgen(2 entities) | 9 | $137 |
| Crossroads Extremity Systems, LLC | 1 | $111 |
| Globus Medical | 3 | $95 |
| Melinta Therapeutics, LLC | 4 | $93 |
| Johnson & Johnson | 2 | $51 |
| Nabriva Therapeutics, PLC | 2 | $45 |
| Bioventus LLC | 1 | $25 |
| Zyla Life Sciences, Inc. | 1 | $22 |
| Arteriocyte Medical Systems, Inc. | 1 | $16 |
| ERMI LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$78,247
- Lapiplasty System$2,494
- CoLink$2,138
- AlloAid Allograft$1,024
- ANCHORAGE$411
- BioBrace 23mm$273
- NeoSpan$165
- IBS$159
- NUZYRA$125
- Medical Implant$111
- FRACTURE AND CORRECTION COLAG 2$108
How this compares
$94,929 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 93 | $943 |
| Mupirocin | 77 | $585 |
| Cephalexin | 12 | $344 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 40 | $209 |
| Allopurinol | 15 | $169 |
| Methylprednisolone | 20 | $140 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $100 |
| Clindamycin Hcl | 11 | $83 |
| Meloxicam | 14 | $20 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Houston
- Kevin VarnerHouston$1.1M
- Sherman NaglerHouston$602K
- Abdul NurudeenHouston$404K
- Orlando RiveraHouston$384K
- Brian LepowHouston$309K
- William GranberryHouston$84K
- Nathaniel AlabiHouston$71K
- Jorge MatukHouston$45K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.